MediciNova is a biopharmaceutical company that is developing
novel therapeutics with a primary focus on neurology, respiratory,
and liver diseases with unmet medical needs.

MN-166 for Neurology Diseases

  • Progressive Multiple Sclerosis
  • Methamphetamine Addiction
  • Neuropathic Pain
Learn More

MN-221 for Respiratory Diseases

  • Acute Exacerbations of Asthma
  • COPD Exacerbations
Learn More

MN-001 for Nonalcoholic Steatohepatitis (NASH)

Learn More